Not exact matches
«We know that 70 - 75 percent of
glioblastoma patients undergo surgery for tumor debulking, and we have previously shown that MSCs encapsulated in biocompatible gels can be used
as therapeutic agents in a mouse model that mimics this debulking,» he continued.
NEW YORK — In 30 years
as an oncologist, Dr. Howard Fine estimates he has treated some 20,000
patients with
glioblastomas, the most deadly form of brain cancer, «and almost all of them are dead.»
ISOMA was launched in 2017 to help advance new treatment paradigms for
glioblastoma patients, which are greatly needed and not in existence
as of today.